Literature DB >> 22682123

Tissue factor proangiogenic signaling in cancer progression.

Florence Schaffner1, Naho Yokota, Wolfram Ruf.   

Abstract

Cancer progression from a dormant, non-vascularized benign tumor to metastatic disease is a multiple steps process that critically depends on contributions from the hemostatic system. Tissue factor (TF), protease activated receptors (PARs), factor VIIa, and the endothelial protein C receptor (EPCR) are expressed by tumor cells as well as the host compartment. These components of the hemostatic system regulate tumor growth, angiogenesis and metastasis. Here we review the evidence that TF-dependent signaling is the major driver of primary tumor growth, whereas TF-initiated coagulation and interactions of procoagulant tumor cells with the host compartments initiate multiple pathways that support and regulate the efficiency of metastatic tumor dissemination.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682123     DOI: 10.1016/S0049-3848(12)70032-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.

Authors:  Kate Burbury; Michael P MacManus
Journal:  Clin Exp Metastasis       Date:  2018-02-28       Impact factor: 5.150

2.  Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.

Authors:  Lan Yang; Yiming Ma; Wenxiao Han; Weiwei Li; Liang Cui; Xinhua Zhao; Yantao Tian; Zhixiang Zhou; Wengong Wang; Hongying Wang
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

3.  PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4.

Authors:  Gregory D Conway; Marguerite S Buzza; Erik W Martin; Nadire Duru; Tierra A Johnson; Raymond J Peroutka; Nisha R Pawar; Toni M Antalis
Journal:  J Mol Med (Berl)       Date:  2019-03-25       Impact factor: 4.599

4.  Thromboembolic disease in patients with high-grade glioma.

Authors:  James R Perry
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

5.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.

Authors:  Lichao Hu; Longfei Xia; Hong Zhou; Biao Wu; Yuan Mu; Ying Wu; Jinchuan Yan
Journal:  Tumour Biol       Date:  2013-04-25

6.  Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach.

Authors:  Bin Zhou; Qi Sun; De-Xin Kong
Journal:  Oncotarget       Date:  2016-05-31

7.  Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.

Authors:  Antonio Colaprico; Claudia Cava; Gloria Bertoli; Gianluca Bontempi; Isabella Castiglioni
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

Review 8.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

9.  Application of Thromboelastography to Predict Lung Cancer Stage.

Authors:  Yaning Zhou; Yijun Guo; Qing Cui; Yun Dong; Xiaoyue Cai; Zhouji Zhang; Xiaoting Wu; Kaiyan Yi; Ming Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.